EUVIMEDEUVIMED entdecken
Crossref

(B3) Markers of Immunodeficiency and Mechanisms of HAART Therapy on Oral Lesions

S R Flint, A Tappuni, J Leigh, A-M Schmidt-Westhausen, L MacPhail

Advances in Dental Research · 2006-04 · 19 (1) · 146-151

DOI: 10.1177/154407370601900126 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advances in Dental Research, online erschienen am 01.04.2006. Verfasst von S R Flint und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial Surgery, Oral Medicine and Oral Pathology, Dublin Dental School and Hospital, Trinity College Dublin, Lincoln Pl…. Hauptthemen laut MEDLINE: Antiretroviral Therapy, Highly Active, Biomarkers. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 58 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Highly active anti-retroviral therapy (HAART) has revolutionized the treatment and prognosis of HIV disease and AIDS in those who can take advantage of the treatment. There are currently 20 different anti-retroviral drugs in 4 different classes that are used in specific combinations. Suppression of HIV replication and immune reconstitution are goals of therapy. Since the prevalence of some easily detectable oral manifestations of HIV/AIDS (OMHIV/AIDS) decreases with HAART, it has been suggested that they might be clinically useful surrogate markers of HAART efficacy and immune status. This might be particularly useful if their recurrence presaged or accompanied HAART failure. To date, there has been little work in this area, but its potential value to the clinical management of HIV/AIDS is apparent, especially if frequent measures of viral load and CD4 cell counts are not readily available. However, the usefulness of OMHIV/AIDS as signals for HAART failure is complicated by three phenomena: the immune reconstitution syndrome, the similarity of some adverse reactions of HAART to OMHIV/AIDS, and the direct inhibitory effect of HAART medications on some OMHIV/AIDS ( e.g., inhibition of oral candidosis by protease inhibitors). This workshop considered the current evidence and proposed pertinent research questions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiretroviral Therapy, Highly ActiveBiomarkersAnti-HIV AgentsCD4 Lymphocyte CountCandidiasis, OralHIV InfectionsHumansImmune System DiseasesInflammationMelanosisMouth DiseasesPapillomavirus InfectionsSalivary Gland DiseasesSyndromeTreatment FailureViral LoadXerostomia

Substanzen

Anti-HIV AgentsBiomarkers

Autor:innen und Institutionen

  • Department of Oral and Maxillofacial Surgery, Oral Medicine and Oral Pathology, Dublin Dental School and Hospital, Trinity College Dublin, Lincoln Place, Dublin 2, Ireland. stephen.flint@dental.tcd.ie

Zitieren

APA

Flint, S. R., Tappuni, A., Leigh, J., Schmidt-Westhausen, A. M., & MacPhail, L. (2006). (B3) Markers of Immunodeficiency and Mechanisms of HAART Therapy on Oral Lesions. Advances in Dental Research, 19(1), 146-151. https://doi.org/10.1177/154407370601900126

Vancouver

Flint SR, Tappuni A, Leigh J, Schmidt-Westhausen AM, MacPhail L. (B3) Markers of Immunodeficiency and Mechanisms of HAART Therapy on Oral Lesions. Advances in Dental Research. 2006;19(1):146-151. doi:10.1177/154407370601900126

BibTeX
@article{Flint2006,
  author = {Flint, S R and Tappuni, A and Leigh, J and Schmidt-Westhausen, A-M and MacPhail, L},
  title = {(B3) Markers of Immunodeficiency and Mechanisms of HAART Therapy on Oral Lesions},
  journal = {Advances in Dental Research},
  year = {2006},
  volume = {19},
  number = {1},
  pages = {146--151},
  doi = {10.1177/154407370601900126}
}
Kostenlos starten →